Table 1. Correlation between the % of reduction in bleeding on marginal probing (BOMP) and changes in the abundance of oral species over time in the therapeutic groups.
Changes in relative abundance post-therapy (T8) | % of reduction in BOMP |
---|---|
Placebo | |
Actinomyces massiliensis | -0.500* |
Actinomyces oris | -0.527* |
Bergeyella HMT-322 | 0.578** |
Prevotella salivae | -0.488* |
Capnocytophaga sp. HMT-336 | 0.485* |
Capnocytophaga sp. HMT-335 | 0.449* |
Probiotic | |
Actinomyces HMT-170 | -0.714** |
Actinomyces HMT-175 | -0.867** |
Bacteroidetes bacterium HMT-365 | 0.644** |
Bacteroidetes bacterium HMT-505 | 0.482* |
Desulfobulbus HMT-041 | 0.505* |
Escherichia coli | 0.698** |
Fretibacterium HMT-358 | 0.698** |
Fusobacterium naviforme | 0.556* |
Fusobacterium HMT-203 | 0.475* |
Leptotrichia HMT-223 | -0.584* |
Leptotrichia wadei | -0.523* |
Pseudoramibacter alactolyticus | 0.698** |
Peptostreptococcaceae [XI][G-5][Eubacterium] saphenum | 0.602** |
Peptostreptococcaceae [XI][G-7][Eubacterium] yurii subsp. schtitka | 0.680** |
Prevotella baroniae | 0.525* |
Prevotella dentalis | 0.698** |
Prevotella enoeca | 0.698** |
Prevotella HMT-443 | 0.505* |
Streptococcus cristatus clade-578 | 0.586* |
Streptococcus oralis subsp.dentisani clade-058 | 0.637** |
Streptococcus gordonii | 0.470* |
Saccharibacteria bacterium HMT-955 | 0.477* |
Treponema HMT-258 | 0.505* |
Treponema HMT-268 | 0.554* |
Treponema HMT-517 | 0.698** |
Veillonellaceae bacterium HMT-135 | 0.505* |
Values represent the Spearman correlation coefficient (rho). Species in green are related to better clinical outcome; i.e. higher reductions in bleeding are correlated with higher abundances of these taxa, whereas increased abundance of species in light orange are associated with more gingival inflammation
(* p < 0.05
** p < 0.01, Mann-Whitney test). T8: 8 weeks after treatments.